We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Smart Intraocular Lens Inserted into the Eye Detects Biomarkers for Alzheimer's

By LabMedica International staff writers
Posted on 13 Jan 2023
Print article
Image: Lens used in the development of smart intraocular lenses (Photo courtesy of KIMM)
Image: Lens used in the development of smart intraocular lenses (Photo courtesy of KIMM)

Scientists have developed a smart intraocular lens that can be inserted into the eye to detect biomarkers for Alzheimer's, a degenerative brain disease, and could facilitate early diagnosis of various other neurological diseases.

The smart intraocular lens that can be inserted into the eye to diagnose Alzheimer's has been developed for the first time in Korea by scientists at The Korea Institute of Machinery and Materials (KIMM, Daejeon, Korea). The intraocular implant can diagnose Alzheimer's in its early stages. The scientists developed the implantable biosensing system by mounting a bioresponsive hydrogel-based sensing module that can detect various biomarkers on an intraocular lens to express a signal in a moiré pattern.

The hydrogel pattern, to which the antibody is bound, contracts when it reacts with the target biomarker which is then detected using changes in the moiré signal. These changes are generated when the hydrogel pattern, which becomes narrower by the contraction response, overlaps with the designated reference grid. The use of a moiré signal makes detection possible with much greater sensitivity as compared to other methods that directly detect change in the hydrogel pattern.

In addition, unlike traditional biosensors, the moiré signal-based biomarker detection method is capable of directly detecting biomarkers without the use of electrochemical or fluorescent labels. This method eliminates the requirement for external power or a light source, allowing it to be implanted within the body. The scientists consider the development of this technology to be significant as it can minimize social costs by diagnosing neurological diseases, including dementia, which is common and results in social issues.

Related Links:
KIMM 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.